THAILAND DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
Thailand Diabetes Care Devices Market is expected to register a CAGR greater than 7% over the forecast period, 2022 - 2027.
The healthcare system was significantly disturbed and pressured during each phase of rapid COVID-19 infection. Several countries, notably the Thai government, have introduced home isolation or a home quarantine program to avert healthcare collapse and to ameliorate inadequate healthcare resources. Between July 2021 and October 2021, COVID-19 illness cases in Thailand increased to around 20,000-25,000 cases per day, posing difficulty in the treatment of COVID-19 infection in hospitals. Previous research revealed the viability of a COVID-19 home monitoring program employing telemedicine to reduce the gap in treatment during a healthcare worker shortage in multiple countries2-5. These programs primarily monitored the intensity of symptoms and informed patients to seek additional treatment if necessary. During COVID-19, there was a shortage of hospital capacity, and a home isolation system was set up. Thailand’s government introduced diabetes self-management education and support (DSMES) and glycemic management via telemedicine, along with outcomes in home-isolated patients with COVID-19 infection. In AUG 2022, The National Research Council of Thailand (NRCT) introduced a breathalyzer prototype that can detect those infected with Covid-19 with 97% accuracy.
Thailand’s government During COVID-19 provided medical supplies, including glucometers, blood glucose test strips, lancets, and urine test strips were donated or purchased using donated funds. The supplies were stocked at a central location and distributed by volunteers, utilizing same-day commercial delivery services. Disposable prefilled insulin pens, both long-acting and short-acting analogs, were chosen instead of insulin vials to reduce administration errors, particularly in insulin-naïve patients. Insulin pens were kept at a medical clinic and distributed in a temperature-controlled container by a same-day delivery service.
Key Market TrendsManagement Devices Segment is Having Highest Share in 2021Blood pressure regulation is a critical component of diabetes management. Furthermore, even in the absence of high blood pressure, certain blood pressure lowering medications are frequently recommended for people living with diabetes to protect them from kidney and heart-related complications. There is currently no scientific evidence linking these blood pressure drugs to the likelihood of COVID-19 infection or associated consequences.
Insulin therapy is the most potent hypoglycaemic medication currently available for diabetes treatment; however, the potency of insulin deteriorates if it is stored under improper conditions. In Thailand, NCDs including diabetes accounts for more than 70% of all deaths. Obesity leads to a more than seven times increase in the risk of developing type 2 diabetes while being overweight increases the risk by three times
Through Thailand’s government encouragement, the usage of Management Devices increased over the forecast period.
Increasing Diabetes population in ThailandThe World Health Organization (WHO) estimates that in 2021, around 11% of the total health expenditure in Thailand is allocated to diabetes care, which is comparable to other countries in the region. By 2030, this figure is expected to grow by 41%, effectively doubling the societal burden of diabetes. In Thailand only 272 endocrinologists (or specialists) are available. In Thailand, three out of five people with diabetes who receive care do not achieve the recommended treatment targets. According to the WHO's report, the world's top five countries suffering from diabetes include Indonesia, China, India, Brazil, and the United States. Thailand is facing an increase in the number of diabetes patients due to the changing lifestyles, which is resulting in the prevalence of obesity. Sedentary lifestyles and unhealthy diets are more common in urban areas of Thailand. The Thai government is attempting to address the threat of diabetes mellitus through programs, like ‘Thailand Healthy Lifestyle Strategic Plan 2011-2020’. Such programs will help diabetic patients understand the benefits of various diabetes devices available in the market.
The increasing diabetes population and the technological advancements in Indonesia are driving the market.
Competitive LandscapeThe new technologies in diabetes devices, like continuous glucose monitoring, increased the market for monitoring devices. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system, rather than merely offering a boost to the continuous glucose monitoring devices market.
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook